The short version of PPARδ fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-27. Anything still debated is marked as such rather than presented as settled.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Typical form of reference material |
| Solubility | Low in water; soluble in DMSO | Used to prepare stock solutions |
| Typical storage | -20 °C, desiccated, protected from light | Common laboratory practice |
| Analytical method | LC-MS/MS | Detects parent compound and metabolites |
| Common test matrix | Urine or blood | Used in anti-doping analysis |
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
== Decision-making == Under Article 11.(c) of the Draft Constitutional Declaration, the Sovereignty Council makes decisions either by consensus, or when consensus is not possible, by a two-thirds majority (eight members).
== Medicine == Researchers in 2011 discovered the ability of graphene to accelerate the osteogenic differentiation of human mesenchymal stem cells without the use of biochemical inducers. In 2015 researchers used graphene to create biosensors with epitaxial graphene on silicon carbide. The sensors bind to 8-hydroxydeoxyguanosine (8-OHdG) and is capable of selective binding with antibodies. The presence of 8-OHdG in blood, urine and saliva is commonly associated with DNA damage. Elevated levels of 8-OHdG have been linked to increased risk of several cancers. By the next year, a commercial version of a graphene biosensor was being used by biology researchers as a protein binding sensor platform. In 2016 researchers revealed that uncoated graphene can be used as neuro-interface electrode without altering or damaging properties such as signal strength or formation of scar tissue. Graphene electrodes in the body are significantly more stable than electrodes of tungsten or silicon because of properties such as flexibility, bio-compatibility and conductivity.
== Ligands and potential ligand-based disease related activities == The functions of FPR3 and the few ligands which activate it have not been fully clarified. Despite its homology to FPR1, FPR3 is unresponsive to many FPR1-stimulating formyl peptides including FMLP. However, fMMYALF, a N-formyl hexapeptide derived from the mitochondrial protein, NADH dehydrogenase subunit 6, is a weak agonist for FPR3 but >100-fold more potent in stimulating FPR1 and FPR2. F2L is a naturally occurring acylated peptide derived from the N-terminal sequence of heme-binding protein 1 by cathepsin D cleavage that potently stimulates chemotaxis through FPR3 in monocytes and monocyte-derived dendritic cells. F2L thereby may be a pro-inflammatory stimulus for FPR3. Similar to FPR2 (see FPR2 section), FPR3 is activated by humanin and thereby may be involved in inhibiting the inflammation occurring in and perhaps contributing to Alzheimer's disease.
In radiology, various X-ray views use terminology based on where the X-ray beam enters and leaves the body, including the front to back view (anteroposterior), the back to front view (posteroanterior), and the side view (lateral).
==== Film ==== MDMA and ecstasy have featured in a number of films, including Trainspotting, Clubbed to Death, Nowhere, Human Traffic, Go, Groove, 24 Hour Party People, Bad Boys II, Party Monster, Layer Cake, Rolling, Enter The Void, Irvine Welsh's Ecstasy, Spring Breakers, MDMA and Beats.
Sources: en.wikipedia.org
Sozusagen Paris, Munich 2016: Hanser. Einbruch der Wirklichkeit: Auf dem Flüchtlingstreck durch Europa, Munich 2016: C. H. Beck. Entlang den Gräben: Eine Reise durch das östliche Europa bis nach Isfahan, Munich 2018: C. H. Beck. Morgen ist da: Reden, Munich 2019: C. H. Beck. Jeder soll von da, wo er ist, einen Schritt näher kommen: Fragen nach Gott, Munich 2022: Hanser. Was jetzt möglich ist: 33 politische Situationen, Munich 2022: C.H. Beck. ISBN 978-3-406-79023-2. Das Alphabet bis S. Roman, Munich 2023: Hanser. ISBN 978-3-446-27745-8. In die andere Richtung jetzt. Eine Reise durch Ostafrika, Munich 2024: C.H. Beck, ISBN 978-3-406-81969-8. with Mehrdad Zaeri (illustration): Zu Hause ist es am schönsten, sagte die linke Hand und hielt sich an der Heizung fest, Berlin 2025: Hanser, ISBN 978-3-446-28260-5. Wenn sich unsere Herzen gleich öffnen. Über Politik und Liebe, Munich 2025: C.H. Beck, ISBN 978-3-406-83887-3. Sommer 24. Roman. Hanser, Berlin 2026, ISBN 978-3-446-28576-7. Köln. E Jeföhl. C.H. Beck, München 2026, ISBN 978-3-406-85095-0.
Cesium atoms was subsequently used to show that single atoms of an element could be counted if its resonance ionization was performed in a counter in which an electron could be detected for an atom in its ground state. Subsequently, advanced techniques categorized under resonance ionization mass spectrometry (RIMS) were used to generate the relative abundance of various ion types by coupling the RIS lasers to magnetic sector, quadrupole, or time-of-flight (TOF) mass spectrometers. The field of resonance ionization spectroscopy (RIS) has largely been shaped by the formal and informal communications heralding its discovery. Research papers on RIS have heavily relied on self-citation from inception, a trend which climaxed three years later with the founding of a company to commercialize the technique.
== History == In the first half of the 20th century there were first attempts to protect people from malaria. At the beginning Pasteur's approach of developing bacterial vaccines was used as a big hope in eradication of this fatal disease. But inactivated malaria sporozoites were ineffective in inducing the protection. In 1948 inactivated merozoites with an adjuvant were used for preventing lethal malaria to kill a group of monkeys. But the strong toxicity of the adjuvant and inability to obtain sufficient count of parasites from human blood stopped further efforts in this way. In 1967 irradiated malaria sporozoites (extracted from salivary glands of infected mosquitos) induced immune response in mice without the need of the adjuvant and similar evidence obtained in human volunteer trials. The mice were exposed to irradiated mosquitos infected by malaria parasites. Mice and volunteers did not acquire malaria because mosquitos and the sporozoites were irradiated and their immune cells triggered response that could protect them from following infection. Yet this approach was not further developed due to problems with obtaining sufficient number of sporozoites and with the harvesting of parasites. Later, modern adjuvants and the possibility of preparing of single parasite proteins provided another way to create a malaria vaccine. RTS,S is a subunit vaccine based on coat protein of sporozoites of the Plasmodium falciparum.
=== Colombia === The Military Forces of Colombia issues the Campaign Ration (Spanish: Ración de Campaña), a dark olive green plastic bag weighing between 1092 and 1205 grams and providing 3,097 to 3,515 kcal (12,960 to 14,710 kJ). Inside are the retort pouch main courses and supplements needed by a soldier for one day. The individual meals, which cater to South American tastes, consist of a breakfast, a lunch, and a main meal (Tamal, envueltos, lentils with chorizo, arvejas con carne, garbanzo beans a la madrileña, arroz atollado, ajiaco con pollo, and sudado con papas y carne). The ration also includes bread products, beverage mixes, candy and accessories. All items except the beverage mixes require no further preparation and can be eaten either hot or cold. The beverage powders must be mixed with hot or cold water before consumption. Each ration also contains raw sugar, a can of condensed milk, sandwich cookies, sweetened and thickened cream spread, hard candy or caramels, peanuts or trail mix or 25 g of roasted almonds, instant coffee, salt, paper towels, a plastic spoon, 2 water purification tablets, and a multivitamin tablet.
Sources: en.wikipedia.org
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.
PPARδ is a nuclear receptor that regulates genes linked to fatty acid oxidation and energy metabolism. Activation can alter lipid handling and energy use in experimental models. The full range of effects in humans is still under study.
The solid compound is generally stable when kept cold, dry, and protected from light. Solutions may degrade faster, so laboratory protocols often specify fresh preparation or cold storage. Stability can depend on solvent, concentration, and container.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.